Catecholamine Vasopressors and the Risk of Atrial Fibrillation After Noncardiac Surgery: A Prospective Observational Study

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2024 Nov 21

PMID 39568780

Authors

Weichao Li

Yuyan Liu

Xunhu Gu

Affiliations

Soon will be listed here.

Abstract

Background: Catecholamine vasopressors are commonly used for intra- or post-operative hypotension for cardiac surgery, which have a side effect of new-onset atrial fibrillation (AF) and myocardial ischemia. However, it is not entirely clear whether catecholamine vasopressors increase the risk of new-onset AF after noncardiac surgery.

Aim: The aim of this study was to analyze the association between the use of catecholamine vasopressors and the risk of developing new-onset AF after noncardiac surgery.

Methods: In this prospective trial, available data from eligible elderly individuals receiving noncardiac surgery at a single center from November 2022 to January 2024 were gathered. Propensity score matching (PSM) was used to balance patient baseline characteristics and to control for confounders. To determine the association between catecholamine vasopressors and the risk of new-onset AF, univariate and multivariate logistic regression analyses were performed.

Results: A total of 6000 subjects were included in this study (mean [SD] age, 70.73 [6.37] years; 910 [50.9%] males). After PSM, the patients were stratified into catecholamine vasopressor (n = 357) and comparator groups (n = 1432). A total of 18/357 patients in the catecholamine vasopressor group developed AF, and 25/1432 patients in the comparator group developed AF (incidence rate, 5.0% vs 1.7%). Compared with the comparator group, the catecholamine vasopressor group had an increased risk of new-onset AF (aOR, 2.77; 95% CI, 1.28-5.89). Some sensitivity analyses also revealed consistent findings of increased new-onset AF risk associated with catecholamine vasopressor treatment.

Conclusion: The findings from this study suggest that catecholamine vasopressor treatment is associated with an increased risk of new-onset AF and may help physicians select a modest medication for patients while also assessing the risk of new-onset AF.

References

AlTurki A, Marafi M, Proietti R, Cardinale D, Blackwell R, Dorian P . Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2020; 13(1):e007437. DOI: 10.1161/CIRCEP.119.007437. View

Wu J, Marchioli R, Silletta M, Masson S, Sellke F, Libby P . Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial. J Am Heart Assoc. 2015; 4(5). PMC: 4599415. DOI: 10.1161/JAHA.115.001886. View

Karamchandani K, Khanna A, Bose S, Fernando R, Walkey A . Atrial Fibrillation: Current Evidence and Management Strategies During the Perioperative Period. Anesth Analg. 2019; 130(1):2-13. DOI: 10.1213/ANE.0000000000004474. View

Bjerrum E, Wahlstroem K, Gogenur I, Burcharth J, Ekeloef S . Postoperative atrial fibrillation following emergency noncardiothoracic surgery: A systematic review. Eur J Anaesthesiol. 2020; 37(8):671-679. DOI: 10.1097/EJA.0000000000001265. View

Chyou J, Barkoudah E, Dukes J, Goldstein L, Joglar J, Lee A . Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association. Circulation. 2023; 147(15):e676-e698. DOI: 10.1161/CIR.0000000000001133. View

Ramlawi B, Otu H, Mieno S, Boodhwani M, Sodha N, Clements R . Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg. 2007; 84(4):1166-72. DOI: 10.1016/j.athoracsur.2007.04.126. View

Desai R, Franklin J . Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019; 367:l5657. DOI: 10.1136/bmj.l5657. View

Ishii Y, Schuessler R, Gaynor S, Yamada K, Fu A, Boineau J . Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005; 111(22):2881-8. DOI: 10.1161/CIRCULATIONAHA.104.475194. View

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

10.

Dobrev D, Aguilar M, Heijman J, Guichard J, Nattel S . Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019; 16(7):417-436. DOI: 10.1038/s41569-019-0166-5. View

11.

Chelazzi C, Villa G, De Gaudio A . Postoperative atrial fibrillation. ISRN Cardiol. 2012; 2011:203179. PMC: 3262508. DOI: 10.5402/2011/203179. View

12.

Hering D, Lachowska K, Schlaich M . Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. Curr Hypertens Rep. 2015; 17(10):80. DOI: 10.1007/s11906-015-0594-5. View

13.

Nattel S, Dobrev D . The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J. 2012; 33(15):1870-7. DOI: 10.1093/eurheartj/ehs079. View

14.

Hajjar L, Vincent J, Galas F, Rhodes A, Landoni G, Osawa E . Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology. 2016; 126(1):85-93. DOI: 10.1097/ALN.0000000000001434. View

15.

Mathew J, Fontes M, Tudor I, Ramsay J, Duke P, Mazer C . A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291(14):1720-9. DOI: 10.1001/jama.291.14.1720. View

16.

Maesen B, Nijs J, Maessen J, Allessie M, Schotten U . Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2011; 14(2):159-74. PMC: 3262403. DOI: 10.1093/europace/eur208. View

17.

Schmittinger C, Torgersen C, Luckner G, Schroder D, Lorenz I, Dunser M . Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012; 38(6):950-8. DOI: 10.1007/s00134-012-2531-2. View

18.

Szczeklik W, LeManach Y, Fronczek J, Polok K, Conen D, McAlister F . Preoperative levels of natriuretic peptides and the incidence of postoperative atrial fibrillation after noncardiac surgery: a prospective cohort study. CMAJ. 2020; 192(49):E1715-E1722. PMC: 7721376. DOI: 10.1503/cmaj.200840. View

19.

Huggett R, Burns J, Mackintosh A, Mary D . Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004; 44(6):847-52. DOI: 10.1161/01.HYP.0000147893.08533.d8. View

20.

Workman A . Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2009; 381(3):235-49. PMC: 2855383. DOI: 10.1007/s00210-009-0474-0. View